deferoxamine mesylate
Generic: deferoxamine mesylate
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
deferoxamine mesylate
Generic Name
deferoxamine mesylate
Labeler
hospira, inc.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
deferoxamine mesylate 2 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
0409-2337
Product ID
0409-2337_ba0ac56a-a16e-4e41-ad3d-623cbd5f2c73
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076019
Listing Expiration
2026-12-31
Marketing Start
2005-03-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04092337
Hyphenated Format
0409-2337
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
deferoxamine mesylate (source: ndc)
Generic Name
deferoxamine mesylate (source: ndc)
Application Number
ANDA076019 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 g/1
Packaging
- 4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ba0ac56a-a16e-4e41-ad3d-623cbd5f2c73", "openfda": {"unii": ["V9TKO7EO6K"], "rxcui": ["1731345", "1731350"], "spl_set_id": ["f9ab6b1c-98d0-4373-0e9b-b10cb4a67543"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15)", "package_ndc": "0409-2337-25", "marketing_start_date": "20050331"}], "brand_name": "Deferoxamine Mesylate", "product_id": "0409-2337_ba0ac56a-a16e-4e41-ad3d-623cbd5f2c73", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "0409-2337", "generic_name": "Deferoxamine Mesylate", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferoxamine Mesylate", "active_ingredients": [{"name": "DEFEROXAMINE MESYLATE", "strength": "2 g/1"}], "application_number": "ANDA076019", "marketing_category": "ANDA", "marketing_start_date": "20050331", "listing_expiration_date": "20261231"}